Cancer Care At The Forefront

Dr. Mona Mazgani in an operating room at Royal Jubilee Hospital with the da Vinci Surgical Robotics System.

Gynecology Oncologist, Dr. Mona Mazgani

Thousands of Islanders receive inpatient cancer care at RJH and VGH every year. In addition to robotics, new equipment being funded through VHF’s campaign is changing the game in terms of cancer care provided locally.

“What I love about practicing in Victoria is that the level of care in our community is much more personalized than what I have seen in bigger centres—and the level of care is just as good. I attribute this to our incredible care teams, and to the incredible donors to the Foundation who ensure we have the specialized equipment we need.

With the right instruments, many of our surgeries can be done laparoscopically meaning that not only do our patients go home sooner and recover faster, they also are left with minimal scarring. The new SPYPHI we will be getting through the campaign is as close as we can get to a crystal ball: it highlights key areas of the body—such as tumors, lymph nodes, and blood vessels—in a distinct colour, to support an incredibly precise removal of the designated tissue, helping to preserve as much of the healthy tissue as possible.

I am just so grateful this campaign is supporting women’s health, and I look forward to sharing more about how we can all elevate this important branch of medicine in the months to come.”

—Dr. Mona Mazgani, Gynecology

Surgeons Dr. Cailan MacPherson, Dr. Sepehr Khorasani, and Dr. Sohrab Khorasani

General Surgery Division Head Dr. Cailan MacPherson (centre), with surgeons Dr. Sepehr Khorasani (left), and Dr. Sohrab Khorasani (right)

“Cancer has touched all of our families somehow. The new technology being funded through the It’s Time for Surgical Innovation campaign is a game-changer. We’re talking about less painful procedures, more precise and sophisticated care, and overall better outcomes for our patients.

With the new equipment we will be able to better localize malignant lymph nodes in patients with abdominal cancers, and general surgeons who treat patients with breast cancer will have a novel technology that will minimize pain and complications. It’s revolutionary.”

—Dr. Cailan MacPherson, Division Head, General Surgery